BAC
Bank of America Corporation
BAC has the edge over FCAP overall, supported by stronger modeled upside and stronger valuation.
FCAP
First Capital, Inc.
FCAP trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FCAP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FCAP's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FCAP.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over FCAP in the historical PE scenario, which offers more potential upside but is not a forecast.
FCAP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $43.83 | -34% |
| Fair | 11x | $62.24 | -5.7% |
| Current | 12x | $66.00 | — |
| Expensive | 17x | $97.27 | +47% |
Historical ranges are pointers, not guarantees.
FCAP's PE is in its fair range at 12x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
FCAP Forward outlook
There aren't enough analyst estimates for FCAP to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
FCAP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $5.72 | +30% |
| Q2 2026 | $5.53 | +40% |
| Q1 2026 | $5.23 | +43% |
| Q4 2025 | $4.90 | +37% |
| Q3 2025 | $4.41 | +25% |
| Q2 2025 | $3.94 | +9.4% |
| Q1 2025 | $3.66 | +2.5% |
| Q4 2024 | $3.57 | -6.8% |
FCAP earned $5.72 per share over the past year, up 30% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
FCAP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.8M | +12% |
| Q2 2026 | $14.3M | +15% |
| Q1 2026 | $13.5M | +18% |
| Q4 2025 | $13.5M | +19% |
| Q3 2025 | $13.3M | +21% |
| Q2 2025 | $12.4M | +16% |
| Q1 2025 | $11.4M | +8.9% |
| Q4 2024 | $11.3M | +9.3% |
FCAP has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 43% | +1 points |
| Q2 2026 | 42% | +4.8 points |
| Q1 2026 | 40% | +5.6 points |
| Q3 2025 | 42% | +10 points |
| Q2 2025 | 37% | +6.2 points |
| Q1 2025 | 34% | +1.2 points |
| Q4 2024 | 35% | +0.2 points |
| Q3 2024 | 31% | -4 points |
FCAP has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FCAP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.8M | -13% |
| Q2 2026 | $3.5M | +2.7% |
| Q1 2026 | $5.9M | +40% |
| Q4 2025 | $4.5M | +21% |
| Q3 2025 | $7.8M | +3.7% |
| Q2 2025 | $3.5M | +3.8% |
| Q1 2025 | $4.2M | -41% |
| Q4 2024 | $3.7M | +385% |
FCAP has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FCAP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FCAP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +748 shares |
| 1 year | -0.2% | -5.7K shares |
| 3 years | -0.4% | -14.6K shares |
| 5 years | -0.3% | -8.8K shares |
| Available history | -0.1% | -3.6K shares |
FCAP has 3M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $517,000 |
| Q3 2025 | $52,000 |
| Q2 2025 | — |
| Q1 2025 | $9,000 |
| Q4 2024 | — |
| Q3 2024 | $28,000 |
| Q2 2024 | $13,000 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FCAP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
| Q2 2024 | -1.5x | Net Cash |
| Q1 2024 | -1.3x | Net Cash |
| Q4 2023 | -1.2x | Net Cash |
FCAP has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FCAP.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FCAP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.3 | Neutral |
| Stochastic | 64.3 | Neutral |
FCAP's weekly RSI is 60 (neutral) and its Stochastic is 64 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FCAP PE vs Financial Services Sector
| Metric | FCAP | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 11% below |
| PE % | 58 | 63 | 5 pts below |
FCAP has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FCAP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.7 | 5.3% above |
| 20 week MA | $62.8 | 5.1% above |
| 50 week MA | $58.6 | 13% above |
| 100 week MA | $49.6 | 33% above |
| 200 week MA | $39.5 | 67% above |
FCAP has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FCAP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $68.5 | $63.1 | -7.9% |
| 2021 | $63.1 | $40.5 | -36% |
| 2022 | $40.5 | $24.4 | -40% |
| 2023 | $24.4 | $27.9 | +14% |
| 2024 | $27.9 | $32.3 | +16% |
| 2025 | $32.3 | $59.9 | +86% |
| 2026 YTD | $59.9 | $66.0 | +10% |
FCAP has the edge over BAC on returns for 2026, with the stronger performance.